The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network

Kelsie Pearson, Nicole Mayer-Hamblett, Christopher H. Goss, George Z. Retsch-Bogart, Jill M. VanDalfsen, Patricia Burks, Daniel Rosenbluth, John Paul Clancy, Amy Hoffman, David P. Nichols

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Fingerprint

Dive into the research topics of 'The impact of SARS-CoV-2 on the cystic fibrosis foundation therapeutics development network'. Together they form a unique fingerprint.

Medicine & Life Sciences